Nature Metabolism Клеточная биология
Hyperandrogenism drives pathogenic adipocyte differentiation to promote insulin resistance in PMOS
Аннотация
Polyendocrine metabolic ovarian syndrome (PMOS) is characterized by hyperandrogenism and insulin resistance, but the mechanisms linking androgen excess to metabolic dysfunction remain unclear. Here we show, using single-nucleus RNA sequencing (snRNA-seq) of visceral adipose tissue from women with PMOS and body mass index-matched controls across normal-weight, overweight and obese groups, that PMOS is associated with the expansion of a distinct preadipocyte population, PreA2, enriched for genetic risk related to both reproductive and metabolic traits. Computational analyses and primary cell experiments identify NR4A1 as a driver of the androgen-associated acquisition of the PreA2 state. Trajectory analyses reveal a C/EBPβ-associated differentiation pathway from PreA2 to an adipocyte state termed Ad3, characterized by increased THBS1 secretion. In human adipocytes exposed to high androgen concentrations, THBS1 knockdown partially restores insulin responsiveness. Related transcriptional features are also observed in the reanalysis of an snRNA-seq dataset generated from visceral adipose tissue of dihydrotestosterone-treated female mice. Our study provides a comprehensive single-nucleus atlas of adipose tissue in PMOS and identifies a preadipocyte differentiation trajectory linking hyperandrogenism-associated adipocyte remodelling to insulin resistance. A preadipocyte subpopulation is expanded in women with PMOS, and hyperandrogenism promotes its aberrant differentiation towards a disease-associated adipocyte state that contributes to insulin resistance.